Average Co-Inventor Count = 5.74
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (18 from 2,405 patents)
2. Merck + Co., Inc. (2 from 4,770 patents)
18 patents:
1. 12365674 - Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection
2. 12281109 - Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetes
3. 9624208 - Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
4. 9399651 - Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
5. 9309199 - Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
6. 9273040 - Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
7. 9260413 - Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
8. 9024032 - Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
9. 8969364 - Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
10. 8530483 - Substituted azabenzoxazoles
11. 8278317 - Potassium channel inhibitors
12. 8148535 - Potassium channel inhibitors
13. 7973059 - Potassium channel inhibitors
14. 7947714 - Piperidine glycine transporter inhibitors
15. 7825135 - Heteroaryl piperidine glycine transporter inhibitors